BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20529600)

  • 1. [Regulatory T lymphocytes expressing L-selectin in children and adolescents with type 1 diabetes mellitus].
    Ryba M; Hak L; Zorena K; Myśliwiec M; Myśliwska J
    Pediatr Endocrinol Diabetes Metab; 2010; 16(1):12-6. PubMed ID: 20529600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T cells with CD62L or TNFR2 expression in young type 1 diabetic patients: relation to inflammation, glycemic control and micro-vascular complications.
    El-Samahy MH; Adly AA; Ismail EA; Salah NY
    J Diabetes Complications; 2015; 29(1):120-6. PubMed ID: 25113439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower frequency of CD62L(high) and higher frequency of TNFR2(+) Tregs are associated with inflammatory conditions in type 1 diabetic patients.
    Ryba M; Rybarczyk-Kapturska K; Zorena K; Myśliwiec M; Myśliwska J
    Mediators Inflamm; 2011; 2011():645643. PubMed ID: 21584225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
    You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential roles of TGF-beta in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells.
    Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y
    J Leukoc Biol; 2008 Feb; 83(2):280-7. PubMed ID: 18029395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-TNF rescue CD4+Foxp3+ regulatory T cells in patients with type 1 diabetes from effects mediated by TNF.
    Ryba M; Marek N; Hak Ł; Rybarczyk-Kapturska K; Myśliwiec M; Trzonkowski P; Myśliwska J
    Cytokine; 2011 Sep; 55(3):353-61. PubMed ID: 21641234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity.
    Goudy KS; Johnson MC; Garland A; Li C; Samulski RJ; Wang B; Tisch R
    Eur J Immunol; 2011 May; 41(5):1480-1490. PubMed ID: 21469091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of the IVS1-397T>C estrogen receptor α polymorphism with the regulatory conditions in longstanding type 1 diabetic girls.
    Ryba M; Malinowska E; Rybarczyk-Kapturska K; Brandt A; Myśliwiec M; Myśliwska J
    Mol Immunol; 2011 Oct; 49(1-2):324-8. PubMed ID: 21943781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.
    You S; Slehoffer G; Barriot S; Bach JF; Chatenoud L
    Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14580-5. PubMed ID: 15340148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice.
    Lepault F; Gagnerault MC
    J Immunol; 2000 Jan; 164(1):240-7. PubMed ID: 10605017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
    Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
    J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
    Chatenoud L
    Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Thymic Output of Effector CD4
    Zhao Y; Alard P; Kosiewicz MM
    J Immunol Res; 2019; 2019():8785263. PubMed ID: 31281853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mRNA expression of pro- and anti-inflammatory cytokines in T regulatory cells in children with type 1 diabetes.
    Łuczyński W; Stasiak-Barmuta A; Juchniewicz A; Wawrusiewicz-Kurylonek N; Iłendo E; Kos J; Kretowski A; Górska M; Chyczewski L; Bossowski A
    Folia Histochem Cytobiol; 2010 Jan; 48(1):93-100. PubMed ID: 20529823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous CD3 expression levels in differing T cell subsets correlate with the in vivo anti-CD3-mediated T cell modulation.
    Valle A; Barbagiovanni G; Jofra T; Stabilini A; Perol L; Baeyens A; Anand S; Cagnard N; Gagliani N; Piaggio E; Battaglia M
    J Immunol; 2015 Mar; 194(5):2117-27. PubMed ID: 25646305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [TNF-α, diabetes type 1 and regulatory T cells].
    Ryba M; Myśliwska J
    Pediatr Endocrinol Diabetes Metab; 2010; 16(4):295-300. PubMed ID: 21447272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulatory T cells in children with acute lymphoblastic leukaemia].
    Stasiak-Barmuta A; Łuczyński W; Iłendo E; Krawczuk-Rybak M; Szymański M
    Med Wieku Rozwoj; 2009; 13(1):53-8. PubMed ID: 19648661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Could the expression of L-selectin be an early marker of arterial hypertension and microangiopathy in the course of type 1 diabetes mellitus in juvenile patients?].
    Pawłowski P; Urban M; Peczyńska J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):147-52. PubMed ID: 16232368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
    Mellanby RJ; Thomas D; Phillips JM; Cooke A
    Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Generation of T regulatory cells in children with type 1 diabetes mellitus].
    Luczyński W; Wawrusiewicz-Kurylonek N; Szypowska A; Iłendo E; Bossowski A; Krętowski A; Głowińska-Olszewska B; Hryszko M; Górska M; Stasiak-Barmuta A
    Pediatr Endocrinol Diabetes Metab; 2011; 17(2):64-70. PubMed ID: 21722510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.